NEW YORK – OpGen announced Tuesday it has issued a formal response to the US Food and Drug Administration's request for additional information for its Acuitas AMR Gene Panel premarket submission.
NEW YORK – OpGen announced Tuesday it has issued a formal response to the US Food and Drug Administration's request for additional information for its Acuitas AMR Gene Panel premarket submission.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.